Lynda Charters

The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.

Clinical pearls on giant cell arteritis (GCA) and optic neuritis

Tools and therapies for dry eye with contact lens wear

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

Optometrists at the forefront of ocular basal cell and squamous cell carcinomas

OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.

SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation

Latest innovations within the presbyopic landscape are proving game-changers for better patient treatment.

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.

Risk factors take priority

The future is sustained-release injectables

Industry keenly focused on innovations

Israeli researchers find a second booster shot was especially effective in individuals over 60 years of age, and “made them three times more resistant to serious illness."

Canadian researchers have found that rapid antigen tests to detect the SARS-CoV-2 virus are associated with a very low rate of false positive results.

Diagnosing COVID-19 just got faster with a test that claims to provide rapid virus detection markedly faster than reverse-transcriptase polymerase chain reaction (RT-PCR) testing.

Investigators report that maintenance hemodialysis does not seem to impact the effectiveness of vaccines against the COVID-19 virus in most study patients.

The WHO alerted the public to a new version of Omicron, BA. 2, following its predecessor, Omicron BA.1.

Significant differences were found in the pupillary diameters between when the virus was active and 3 months later, Turkish investigators report.

Manufacturing of the omicron-specific vaccine has already begun.

Saudi Arabian investigators have determined that Vitamin D levels are not protective against the severity or the outcomes of COVID-19 infections.

Genetics researchers reported identifying a genetic link to the biologic mechanisms responsible for COVID-19-related loss of smell or taste.

Signs of the SARS-CoV-2 virus in human ocular tissues samples post-mortem were found to be low in samples considered suitable for corneal recovery and transplantation.

Acute corneal endothelial rejection is a possibility soon after either the first or second dose of the COVID-19 messenger RNA (mRNA) vaccine (Moderna), according new research.

Danish researchers report a significantly increased association between the mRNA-1273 vaccination (Moderna) and development of myocarditis or myopericarditis.